Arbutus Biopharma Corp

Lician Pro · $19.99/mo or $149/yr · AAPL vs MSFT

Arbutus Biopharma Corp (ABUS) SEC filings

Arbutus Biopharma Corp (ABUS) SEC filings — 10-K, 10-Q, 8-K, and Form 4 as cached from EDGAR. When an exhibit lands, this page shows the headline, the numbers, and why it matters.

Those exhibit numbers sit next to the income-statement cache: Latest reported ABUS revenue for 2025-12-31 was $14.1M. Net income was -$33.5M. Revenue was up 128.2% from 2024-12-31 to 2025-12-31. ABUS currently screens at market cap $883.0M. The ABUS filings page is the source view; the stock page is the research view.

EDGAR remains the official archive. Lician caches 8-K exhibits so you can read what Arbutus Biopharma Corp said without waiting on a live EDGAR scrape. Item 2.02 is the earnings exhibit — this page prefers EX-99.1 revenue, growth, EPS, and guidance over a form-type label. Form 4 insider prints stay on the same ticker timeline.

Earnings & events

All events

Event insights for ABUS — what management said, what changed, and why it matters.

Recent filings

These filings as JSON? API free 100/day

ABUS SEC filings FAQ

What is the latest ABUS SEC filing?

The latest cached Arbutus Biopharma Corp (ABUS) filing on this page is 8-K · Aug 21, 2026. Filings: https://lician.com/sec/abus

What is the latest ABUS filing accession number?

The latest cached Arbutus Biopharma Corp (ABUS) accession number on this page is 0001104659-26-099390. Filing: https://lician.com/sec/abus/0001104659-26-099390

Which item codes are on the latest ABUS filing?

Cached item codes on the latest Arbutus Biopharma Corp (ABUS) 8-K are 8.01, 9.01.

How many ABUS SEC filings are listed on this page?

This page lists 4 cached Arbutus Biopharma Corp (ABUS) SEC filings. Filings: https://lician.com/sec/abus

What events are listed on the ABUS SEC page?

Cached event headlines on this Arbutus Biopharma Corp (ABUS) SEC page: "ABUS earnings". Events: https://lician.com/sec/abus

What are ABUS's latest revenue and net income?

Latest cached Arbutus Biopharma Corp (ABUS) revenue for Dec 31, 2025 was $14.1M. Net income was -$33.5M. Statements: https://lician.com/financials/abus